Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-Reactive Protein.

This study, besides defining a serum panel for glioblastoma discrimination, identified IL1β as a potential candidate for developing targeted therapy. PMID: 26232108 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26232108?dopt=Abstract

Source: Journal of Proteomics - July 28, 2015 Category: Biochemistry Authors: Nijaguna MB, Schröder C, Patil V, Sd S, Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V, Hoheisel JD, Somasundaram K Tags: J Proteomics Source Type: research